Takeda Pharmaceuticals, Japan's largest drugmaker, has undergone a sweeping transformation under CEO Christophe Weber, ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Thousands crowded San Francisco’s Japantown on Sunday for the 58th annual Cherry Blossom Festival. Kiyomi Takeda, who’s part ...

Takeda is to acquire TiGenix, the stem cell specialist biotech with which it has developed a gastro stem cell therapy, in a deal worth 520 million euros ($626 million). The decision follows ...

LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage ...

Takeda (TAK) Canada announced that Health Canada has expanded the marketing authorization for HyQvia for chronic inflammatory demyelinating polyneuropathy as maintenance therapy after ...

Belo, a member of PRWeek’s 2024 Health Influencer list, joined Takeda in 2021 as VP and global head of external communications. The company promoted him to SVP and head of global corporate brand and ...

Takeda Machinery Co. Ltd. (6150.TO) Japan Nine Months Ended February 28 GROUP 2025 2024 Revenue Y3.65 bln Y4.03 bln Operating Profit Y339.00 mln Y524.00 mln Pretax Profit Y349.00 mln Y541.00 mln Net ...

Takeda Vietnam has announced the appointment of its General Manager, Benjamin Ping, a pharmaceutical executive with more than ...

Canada announced that Health Canada has expanded the marketing authorization for HyQvia for chronic inflammatory demyelinating ...